Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Eledon Pharmaceuticals (ELDN) Receivables - Other (2018 - 2021)

Eledon Pharmaceuticals filings provide 1 years of Receivables - Other readings, the most recent being $250000.0 for Q4 2014.

  • On a quarterly basis, Receivables - Other changed N/A to $250000.0 in Q4 2014 year-over-year; TTM through Dec 2014 was $250000.0, a N/A change, with the full-year FY2014 number at $250000.0, changed N/A from a year prior.
  • Receivables - Other hit $250000.0 in Q4 2014 for Eledon Pharmaceuticals.
  • In the past five years, Receivables - Other ranged from a high of $250000.0 in Q4 2014 to a low of $250000.0 in Q4 2014.